These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The model of height prognosis in children with growth hormone deficiency]. Kostecka L; Wasikowa R; Noczyńska A; Filipowski H Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):113-7. PubMed ID: 15504314 [TBL] [Abstract][Full Text] [Related]
3. [Correlation between expression of vascular endothelial growth factor and prognosis of patients with esophageal squamous cell carcinoma]. Hu CZ; Wang YX; Zhang XZ Ai Zheng; 2002 Mar; 21(3):301-4. PubMed ID: 12452000 [TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021 [TBL] [Abstract][Full Text] [Related]
5. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia. Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma. Luo Y; Qiu Z; Tian L; Zhu G; Feng Y; Yi M; Chen X; Wang L; Li C; Huang Q Hum Pathol; 2013 Jan; 44(1):69-76. PubMed ID: 22939953 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353 [TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of the intrinsic growth deceleration of the first passage xenografts of human renal cell carcinomas. Bassukas ID; Hofmockel G; Tsatalpas P; Eberle V; Maurer-Schultze B Cancer; 1996 Nov; 78(10):2170-2. PubMed ID: 8918411 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035 [TBL] [Abstract][Full Text] [Related]
10. Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Deniz ML; Kiliç T; Almaata I; Kurtkaya O; Sav A; Pamir MN Neurosurgery; 2002 Sep; 51(3):753-60; discussion 760. PubMed ID: 12188955 [TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423 [TBL] [Abstract][Full Text] [Related]
12. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095 [TBL] [Abstract][Full Text] [Related]
13. [Expression of hepatocyte growth factor, transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrative gastric cancer and their relations with defluxion of gastric cancer cell and prognosis]. Li CF; Wei YZ; Xue YW Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):206-9. PubMed ID: 19563076 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer. Hu L; Cong L Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668 [TBL] [Abstract][Full Text] [Related]
15. Advances in insulin like growth factor binding protein 1 in the prognosis of acute myocardial infarction. Hui L; Hui P; Feng-ying G Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):22-4. PubMed ID: 21375933 [TBL] [Abstract][Full Text] [Related]
16. [Is it possible to improve the prognosis of growth?]. Weill J; Bernfeld J Cah Med; 1970 Mar; 11(3):213-9. PubMed ID: 5441417 [No Abstract] [Full Text] [Related]
17. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842 [TBL] [Abstract][Full Text] [Related]
18. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin. Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696 [TBL] [Abstract][Full Text] [Related]
19. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis. García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909 [TBL] [Abstract][Full Text] [Related]
20. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer. Hu Y; Hu MM; Shi GL; Han Y; Li BL Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]